New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
09:58 EDTRSTI, PRGO, VRSN, MMS, DO, CS, CHK, SPR, OUTR, WWWW, CI, PMFG, IRBT, FWM, AOL, GHDX, FLDM, LOW, G, ELONOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AOL (AOL) downgraded to Neutral from Buy at BofA/Merrill... Echelon (ELON) downgraded to Hold from Buy at Needham... Fairway Group (FWM) downgraded to Hold from Buy at BB&T... Fluidigm (FLDM) downgraded to Market Perform from Outperform at Cowen... Genomic Health (GHDX) downgraded to Neutral from Outperform at Credit Suisse... Genpact (G) downgraded to Neutral from Overweight at JPMorgan... iRobot (IRBT) downgraded to Underweight from Neutral at JPMorgan... Lowe's (LOW) downgraded to Neutral from Buy at Goldman... Maximus (MMS) downgraded to Neutral from Buy at Citigroup... PMFG, Inc. (PMFG) downgraded to Hold from Buy at Stifel... Spirit AeroSystems (SPR) downgraded to Hold from Buy at KeyBanc... VeriSign (VRSN) downgraded to Sell from Neutral at Citigroup... Cigna (CI) downgraded to Neutral from Positive at Susquehanna... Chesapeake (CHK) downgraded to Sector Perform from Outperform at Howard Weil... Perrigo (PRGO) downgraded to Neutral from Buy at B. Riley... Web.com (WWWW) downgraded to Hold from Buy at Craig-Hallum... Credit Suisse (CS) downgraded to Neutral from Outperform at Macquarie... Rofin-Sinar (RSTI) downgraded to Neutral from Buy at Longbow... Outerwall (OUTR) downgraded to Market Perform from Outperform at Northland Securities... Diamond Offshore (DO) downgraded to Sell from Neutral at Global Hunter.
News For AOL;ELON;FLDM;FWM;G;GHDX;IRBT;LOW;MMS;PMFG;SPR;VRSN;CI;CHK;PRGO;WWWW;CS;RSTI;OUTR;DO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 8, 2015
11:51 EDTPRGOPerrigo calls active on Mylan proposal to acquire for $205 per share
Subscribe for More Information
11:45 EDTPRGOMylan volatility up after proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:40 EDTPRGOPerrigo up $47.10 to $211.81, trading above Mylan's $205/share proposal
Subscribe for More Information
11:35 EDTPRGOGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
Subscribe for More Information
11:34 EDTPRGOGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
11:32 EDTPRGOMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:31 EDTPRGOPerrigo halted for volatility after jumping 7% to $176.42
Subscribe for More Information
11:29 EDTAOLOptions with increasing implied volatility
Subscribe for More Information
11:29 EDTPRGOMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
08:56 EDTPRGOPerrigo's ANDA for equivalent of Mallinckrodt's Exalgo approved by FDA
Subscribe for More Information
08:45 EDTFLDMLife Sciences group well positioned heading into Q1 earnings, says Cowen
Cowen said the Life Sciences sector looks well positioned heading into Q1 earnings despite the group outperforming the broader market recently. The firm believes headwinds have intensified and multiples have stretched, but they see the downside risk as limited with upside risk dependent on improving end-market commentary, new products and milestones, and new details on capital deployment. Stocks in the space include Affymetrix (AFFX), Fluidigm (FLDM), GenMark (GNMK), Myriad Genetics (MYGN) and Quidel (QDEL).
07:24 EDTCSNeurotechnology Industry Organization to hold a conference
Subscribe for More Information
April 7, 2015
12:36 EDTAOLOptions with increasing implied volatility
Subscribe for More Information
10:23 EDTCIMedicare Advantage 2016 rates set above expectations
The U.S. yesterday announced higher than expected 2016 Medicare Advantage reimbursement rates. The news is seen as benefiting managed care companies with large exposure to the Medicare Advantage program. WHAT'S NEW: The Centers for Medicare and Medicaid Services, or CMS, yesterday afternoon announced that Medicare Advantage reimbursement rates would rise 1.25% in 2016 from 2015 levels. In February, CMS proposed a 0.95% reduction in Medicare Advantage reimbursement rates for 2016. This year, reimbursement rates have fallen 4%. WHAT'S NOTABLE: Humana (HUM) said this morning in a regulatory filing that based on its review of the Final Rate Notice, the company expects an average Medicare Advantage funding increase for its business of approximately 0.8% from CMS for 2016, versus a funding decline of 1.25%-1.75% previously expected based on the Advance Notice. Humana’s estimated year-over-year funding increase as it affects the company is projected to be less than the CMS estimate for the MA program primarily due to Humana’s view of the projected impact associated with CMS’ 2016 adjustment to the risk model calculation, the company explained. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Scott Fidel wrote that this is the first time in seven years that CMS has implemented an increase in Medicare Advantage rates. However, noting that CMS said it had raised its estimates for Medicare costs, Fidel added that this forecast tempered the positive outlook created by the reimbursement increase. The analyst kept Buy ratings on the following stocks in the sector: Aetna (AET), Anthem (ANTM), Cigna (CI), Magellan Health (MGLN), and UnitedHealth (UNH). Stifel analysts said that the results were modestly better than expected, except for the agency's decision not to make a Star rating adjustment for plans with certain higher acuity populations. The firm thinks that more diversified managed care companies with Medicare Advantage products could be boosted by CMS' decision, identifying Aetna, Humana, and UnitedHealth as being among the companies in that category. PRICE ACTION: In early trading, Aetna was little changed at $107.40, Anthem was flat near $155 per share, Cigna slipped 0.4% to $131.34, Magellan was flat at $71, UnitedHealth added 0.5% to $118.31 and Humana gained fractionally to $178.54.
08:20 EDTCICowen expects managed care stocks to outperform following CMS release
Cowen expects managed care stocks to outperform today following the CMS release outlining better than expected Medicare Advantage rates for 2016. The firm also sees improved FFS growth rates, maintained coding intensity adjustment, and continued HRA payments. Publicly traded companies in the space include Aetna (AET), Cigna (CI), Health Net (HNT), Humana (HUM), and WellCare (WCG).
07:57 EDTCIManaged care companies likely to rise on CMS news, says Oppenheimer
Subscribe for More Information
07:41 EDTCI2016 MA rates positive for first time in seven years, says Deutsche Bank
Deutsche Bank notes that for the first time since 2009, Medicare Advantage rates will be positive after the Centers for Medicare and Medicaid Services announced yesterday that final 2016 rates will rise by 1.25%, representing a 220 basis points favorable swing from the preliminary proposed cut of 0.95%. Deutsche says the positive surprise is "somewhat tempered" by the more cautious view on Medicare cost trends provided by the CMS actuaries in the final 2016 rate announcement. The firm expects Humana (HUM), Health Net (HNT) and UnitedHealth (UNH), Aetna (AET) and Anthem (ANTM) to experience Medicare Advantage rate increases.
April 6, 2015
10:09 EDTOUTRHigh option volume stocks
High option volume stocks: DBA DLPH OUTR PNK TROW SLCA MTB EMR MTG IVZ
07:57 EDTCILeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte discusses the leverage Anthem likely has in its Pharmacy Benefit Manager (PBM) contract with Express Scripts and how it changes after the Catamaran-Optum Rx deal, the synergy potential for the deal between Catamaran and Optum Rx and the likelihood of Cigna-HS remaining with the newly merged Optum Rx-CTRX on an Analyst/Industry conference call to be held on April 6 at 2 pm.
06:05 EDTWWWWWeb.com risk/reward favorable into turnaround, says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use